Cardiology Today -- In patients with acute ischemic stroke being treated with intravenous tissue plasminogen activator, baseline warfarin use increased the risk for symptomatic intracerebral hemorrhage, even with an international normalized ratio less than 1.7, according to the findings of a retrospective study.
